Bio-Thera Gets Chinese Nod To Proceed On Ustekinumab

China’s NMPA Gives Go-Ahead For Phase I Trial On Stelara Biosimilar

 
• By Penelope MacRae
China
China has given Bio-Thera approval to proceed with a Phase I ustekinumab trial • Source: Shutterstock

More from Biosimilars

More from Products